 Healthy toddlers, children, adolescents and adults, aged 1 year and older will receive two doses of vaccine 14 days apart, and will be assessed baseline immunogenicity pre-vaccination, and 14 days after each vaccine dose. Safety data will be collected for 14 days after the first dose and 30 days after the second dose. 